查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1701353

脸部注射剂市场规模、份额、趋势分析报告：按产品、应用、最终用途、地区和细分市场预测，2025 年至 2030 年

Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen & PMMA Microspheres, HA), By Application (Facial Line Correction, Lip Augmentation), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

脸部注射剂市场的成长和趋势

根据 Grand View Research, Inc. 的一份新报告，全球脸部注射剂市场预计到 2030 年将达到 249 亿美元，2025-2030 年期间的复合年增长率为 12.3%。

脸部注射剂是抗衰老治疗的重要组成部分，尤其是用于阻止色素沉着和过早衰老等损害。在所有社会经济群体中最受欢迎的治疗方法是肉毒桿菌和填充剂，它们已经获得了极大的欢迎。

人们越来越重视外表，尤其是在新兴国家，这是预计推动市场发展的主要因素之一。此外，消费者对微创手术的偏好转变也有望支持市场成长。根据美国整形外科医师协会 (ASPS) 的数据，肉毒桿菌毒素 A 和软组织填充剂位列 2020 年实施的五大微创手术之列。

2020 年第一季季和第二季度，受疫情影响，非紧急整容手术被搁置。冠状病毒疫情影响了所有行业，包括化妆品行业，因为当局采取了严格的限制措施作为预防措施。美容相关产品的供应链也受到了影响。整个医疗设备领域的供需链因疫情而受到严重扰乱。

脸部注射剂市场报告重点

  • 根据产品类型，A 型肉毒桿菌毒素预计将在整个预测期内占据市场主导地位。它是最常用的微创手术之一。
  • 根据应用，脸部线条矫正部分将占据市场主导地位，到 2024 年将占据 33.2% 的最大收益占有率。这种增长是由于脸部注射剂在面部线条、面部皱纹和唇线等美容手术中的使用越来越多。
  • 根据最终用途，医疗水疗领域将占据市场主导地位，到 2024 年将占据 47.0% 的最大收益占有率。这些设施提供所有非侵入性治疗，例如脸部注射、非侵入性身体塑形、活肤、雷射治疗等，均由经验丰富的专业人员执行。
  • 由于产品容易取得且拥有大量熟练的外科医生，北美将占据市场主导地位，2024 年的收入份额将达到 38.9%。
  • 亚太地区有望成为主要的产生收入中心。该地区受到印度等国家的支持，这些国家对外观的日益关注有望为市场创造丰厚的机会。

目录

第一章调查方法与范围

第二章执行摘要

第三章面部注射市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 脸部注射市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析

第四章脸部注射剂市场：按产品的估计和趋势分析

  • 全球脸部注射剂市场：产品仪表板
  • 全球脸部注射剂市场：产品差异分析
  • 全球脸部注射剂市场（按产品和收益）
  • 胶原蛋白和PMMA微球
  • A型肉毒桿菌毒素
  • HA
  • CaHA
  • PLLA
  • 其他的

第五章脸部注射剂市场：按应用的估计和趋势分析

  • 全球脸部注射剂市场：应用仪表板
  • 全球脸部注射剂市场：应用趋势分析
  • 按用途分類的收益
  • 脸部线条矫正
  • 丰唇
  • 拉皮
  • 痤疮疤痕的治疗
  • 脂肪营养障碍的治疗
  • 其他的

第六章脸部注射剂市场：按最终用途的估计和趋势分析

  • 全球脸部注射剂市场：最终用途仪表板
  • 全球脸部注射剂市场：最终用途差异分析
  • 按最终用途分類的收益
  • 医疗水疗中心
  • 皮肤科诊所
  • 医院
  • 其他的

第七章脸部注射剂市场：按产品、应用、最终用途和地区进行的估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争格局

  • 公司/竞争对手分类
    • 主要企业市场占有率分析（2024年）
    • Ispen
    • Abbvie
    • Medytox Inc.
    • Merz GmbH and Co. KGaA
    • Revance Therapeutics, Inc.
    • Galderma
    • Sinclair Pharma
Product Code: GVR-1-68038-849-7

Facial Injectable Market Growth & Trends:

The global facial injectable market size is expected to reach USD 24.9 billion by 2030, registering a CAGR of 12.3% from 2025 to 2030, according to a new report by Grand View Research, Inc., The facial injectables are crucial in anti-aging treatments and are particularly used to stop damage such as hyperpigmentation and early aging. The most popular treatments across all socioeconomic groups are Botox and fillers, which have gained immense popularity.

Growing focus on physical appearance, especially in developing countries is one of the key factors expected to drive the market. In addition, a shift in consumer preference towards minimally invasive procedures is also expected to support market growth. According to the American Society of Plastic Surgeons (ASPS), in 2020, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.

The onset of the pandemic led to nonurgent and cosmetic surgeries being put on hold in the first and second quarters of 2020. Since there were stringent restrictions imposed by the authority bodies as a precaution, the coronavirus outbreak has had an impact on every industry, including the cosmetics industry. Aesthetics-related product supply chains were also impacted. The demand-supply chain across the whole medical device sector has been severely disrupted by the pandemic.

Facial Injectable Market Report Highlights:

  • Based on product, the botulinum toxin type A segment is projected to dominate the market throughout the forecast period. It is one of the most popularly used minimally invasive procedures
  • Based on application, the facial line correction segment dominated the market and accounted for the largest revenue share of 33.2% in 2024. This growth is owing to the increasing use of facial injectables for aesthetic procedures such as facial lines, wrinkles on the face, and lip lines
  • Based on end-use, the medSpa segment dominated the market and held the largest revenue share of 47.0% in 2024. All noninvasive treatments are performed in these facilities, which include facial injections, non-invasive body contouring, skin rejuvenation, and laser treatments by experienced professionals
  • North America dominated the market with a revenue share of 38.9% in 2024 owing to the easy availability of the products and the presence of a large number of skilled surgeons
  • The Asia Pacific region is expected to serve as a key revenue-generating center. The region is backed by countries such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity for the market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Facial Injectable Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing beauty consciousness among consumers
      • 3.2.1.2. Shift in consumer preference towards minimally invasive procedures
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of treatment
  • 3.3. Facial Injectable Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Facial Injectable Market: Product Estimates & Trend Analysis

  • 4.1. Global Facial Injectable Market: Product Dashboard
  • 4.2. Global Facial Injectable Market: Product Movement Analysis
  • 4.3. Global Facial Injectable Market by Product, Revenue
  • 4.4. Collagen & PMMA Microspheres
    • 4.4.1. Collagen & PMMA microspheres market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Botulinum Toxin Type A
    • 4.5.1. Botulinum toxin Type A market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. HA
    • 4.6.1. HA market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. CaHA
    • 4.7.1. CaHa market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. PLLA
    • 4.8.1. PLLA market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Facial Injectable Market: Application Estimates & Trend Analysis

  • 5.1. Global Facial Injectable Market: Application Dashboard
  • 5.2. Global Facial Injectable Market: Application Movement Analysis
  • 5.3. Global Facial Injectable Market Estimates and Forecasts, By Application, Revenue (USD Million)
  • 5.4. Facial Line Correction
    • 5.4.1. Facial line correction market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Lip Augmentation
    • 5.5.1. Lip augmentation market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Face Lift
    • 5.6.1. Face lift market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Acne Scar Treatment
    • 5.7.1. Acne scar treatment market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Lipoatrophy Treatment
    • 5.8.1. Lipoatrophy treatment market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Facial Injectable Market: End Use Estimates & Trend Analysis

  • 6.1. Global Facial Injectable Market: End use Dashboard
  • 6.2. Global Facial Injectable Market: End use Movement Analysis
  • 6.3. Global Facial Injectable Market Estimates and Forecasts, by End use, Revenue (USD Million)
  • 6.4. MedSpa
    • 6.4.1. MedSpa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Dermatology Clinics
    • 6.5.1. Dermatology Clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Hospitals
    • 6.6.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Facial Injectable Market: Regional Estimates & Trend Analysis by Product, Application, and End use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
    • 8.1.1. Key company market share analysis, 2024
    • 8.1.2. Ispen
      • 8.1.2.1. Company overview
      • 8.1.2.2. Financial performance
      • 8.1.2.3. Product benchmarking
      • 8.1.2.4. Strategic initiatives
    • 8.1.3. Abbvie
      • 8.1.3.1. Company overview
      • 8.1.3.2. Financial performance
      • 8.1.3.3. Product benchmarking
      • 8.1.3.4. Strategic initiatives
    • 8.1.4. Medytox Inc.
      • 8.1.4.1. Company overview
      • 8.1.4.2. Financial performance
      • 8.1.4.3. Product benchmarking
      • 8.1.4.4. Strategic initiatives
    • 8.1.5. Merz GmbH and Co. KGaA
      • 8.1.5.1. Company overview
      • 8.1.5.2. Financial performance
      • 8.1.5.3. Product benchmarking
      • 8.1.5.4. Strategic initiatives
    • 8.1.6. Revance Therapeutics, Inc.
      • 8.1.6.1. Company overview
      • 8.1.6.2. Financial performance
      • 8.1.6.3. Product benchmarking
      • 8.1.6.4. Strategic initiatives
    • 8.1.7. Galderma
      • 8.1.7.1. Company overview
      • 8.1.7.2. Financial performance
      • 8.1.7.3. Product benchmarking
      • 8.1.7.4. Strategic initiatives
    • 8.1.8. Sinclair Pharma
      • 8.1.8.1. Company overview
      • 8.1.8.2. Financial performance
      • 8.1.8.3. Product benchmarking
      • 8.1.8.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Facial Injectable Market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 U.S. Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 Canada Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 12 Europe Facial Injectable Market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 15 Europe Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 16 Germany Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 19 UK Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 22 France Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 23 France Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 24 France Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 25 Italy Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 28 Spain Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 31 Denmark Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 32 Denmark Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 33 Denmark Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34 Sweden Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 35 Sweden Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 36 Sweden Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 37 Norway Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 38 Norway Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 39 Norway Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Facial Injectable Market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 44 China Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 45 China Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 46 China Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 47 Japan Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 49 Japan Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 50 India Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 51 India Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 52 India Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 53 South Korea Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 54 South Korea Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 55 South Korea Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 56 Australia Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 57 Australia Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 58 Australia Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 59 Thailand Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 60 Thailand Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 61 Thailand Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 62 Latin America Facial Injectable Market, by region, 2018 - 2030 (USD Million)
  • Table 63 Latin America Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 64 Latin America Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 65 Latin America Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 66 Brazil Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 67 Brazil Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 69 Mexico Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 70 Mexico Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 72 Argentina Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 75 MEA Facial Injectable Market, by region, 2018 - 2030 (USD Million)
  • Table 76 MEA Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 77 MEA Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 78 MEA Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 79 South Africa Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 85 UAE Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Facial Injectable Market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Facial Injectable Market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Facial Injectable Market: market outlook
  • Fig. 9 Facial injectables competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Facial Injectable Market driver impact
  • Fig. 13 Facial Injectable Market restraint impact
  • Fig. 14 Facial Injectable Market: Product movement analysis
  • Fig. 15 Facial Injectable Market: Product outlook and key takeaways
  • Fig. 16 Collagen & PMMA microspheres market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Botulinum toxin Type A market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 HA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 CaHA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 PLLA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Facial Injectable Market: Application movement analysis
  • Fig. 23 Facial Injectable Market: Application outlook and key takeaways
  • Fig. 24 Facial Line Correction market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Lip augmentation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Face lift market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Acne scar treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Lipoatrophy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Facial Injectable Market: End use movement analysis
  • Fig. 31 Facial Injectable Market: End use outlook and key takeaways
  • Fig. 32 MedSpa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Dermatology clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Global Facial Injectable Market: Regional movement analysis
  • Fig. 36 Global Facial Injectable Market: Regional outlook and key takeaways
  • Fig. 37 Global Facial Injectable Market share and leading players
  • Fig. 38 North America, by country
  • Fig. 39 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. key country dynamics
  • Fig. 41 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Canada key country dynamics
  • Fig. 43 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 UK key country dynamics
  • Fig. 46 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Germany key country dynamics
  • Fig. 48 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 France key country dynamics
  • Fig. 50 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Italy key country dynamics
  • Fig. 52 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Spain key country dynamics
  • Fig. 54 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark key country dynamics
  • Fig. 56 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden key country dynamics
  • Fig. 58 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Norway key country dynamics
  • Fig. 60 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 China key country dynamics
  • Fig. 63 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Japan key country dynamics
  • Fig. 65 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 India key country dynamics
  • Fig. 67 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Thailand key country dynamics
  • Fig. 69 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 South Korea key country dynamics
  • Fig. 71 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Australia key country dynamics
  • Fig. 73 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Brazil key country dynamics
  • Fig. 76 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Mexico key country dynamics
  • Fig. 78 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Argentina key country dynamics
  • Fig. 80 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 South Africa key country dynamics
  • Fig. 83 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Saudi Arabia key country dynamics
  • Fig. 85 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 UAE key country dynamics
  • Fig. 87 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Kuwait key country dynamics
  • Fig. 89 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)